The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Share
More article options
Full text access
Is it better to use an ACE inhibitor (lysinopril) rather than a calcium-channel blocker (amlodipine) for managing hypertension patients with high cardiovascular risk?
¿Es preferible utilizar un inhibidor de la ECA (lisinopril) a un antagonista del calcio (amlodipino) en el tratamiento de hipertensos con alto riesgo cardiovascular?
Visits
4304
R. Marín Iranzo
This item has received
Article information




